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Abstract. Bayesian network analysis is a form of probabilistic modeling which derives from empirical data a directed acyclic
graph (DAG) describing the dependency structure between random variables. Bayesian networks are increasingly ﬁnding
application in areas such as computational and systems biology, and more recently in epidemiological analyses. The key
distinction between standard empirical modeling approaches, such as generalised linear modeling, and Bayesian network
analyses is that the latter attempts not only to identify statistically associated variables, but to additionally, and empirically,
separate these into those directly and indirectly dependent with one or more outcome variables. Such discrimination is vastly
more ambitious but has the potential to reveal far more about key features of complex disease systems. Applying Bayesian
network modeling to biological and medical data has considerable computational demands, combined with the need to ensure
robust model selection given the vast model space of possible DAGs. These challenges require the use of approximation
techniques, such as the Laplace approximation, Markov chain Monte Carlo simulation and parametric bootstrapping, along
with computational parallelization. A case study in structure discovery - identiﬁcation of an optimal DAG for given data - is
presented which uses additive Bayesian networks to explore veterinary disease data of industrial and medical relevance.
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INTRODUCTION
Analysing observational data in order to provide insight
into potential causes of disease, and factors associated
with increased risk of exposure is extremely common in
both human and veterinary medicine. From a data analy-
sis perspective this is often far from trivial. Diseases and
health conditions which are a priority for control or erad-
ication in humans and animals are increasingly recog-
nised to have highly complex determinants. For exam-
ple, many diseases with high global burdens are endemic
as a result of a multitude of different factors, some bi-
ological - properties of the pathogen - but also numer-
ous inter-related social and economic conditions which
provide an environment in which exposure is probable.
Analysing observational data - realisations from the un-
known stochastic processes which describe such epi-
demiological systems - is best served by a methodology
which focuses neither on a single dependent variable, e.g.
as in generalised linear modeling (GLM) with disease
presence as the response variable, or some opaque di-
mension reduction technique such as factor or principal
component analysis. Consider instead, additive Bayesian
Networks (ABN), a form of graphical modeling which
generalises the usual GLM to multiple dependent vari-
ables and involves no dimension reduction. We present
here additive Bayesian Networks (ABN) as a data analy-
sis tool for epidemiological systems analysis.
Statistical modeling of observational data presents
considerable challenges; unlike in controlled experi-
ments it is not generally possible to disentangle the ef-
fect of any individual covariate from another. Yet, in or-
der to provide meaningful epidemiological interpretation
of such data, attempts must be made to identify what
potential relationships might be present between one or
more outcomes of interest and risk factors (covariates).
This is a long standing problem of major practical im-
portance in epidemiology. Multivariable regression - one
dependent variable and multiple independent variables -
is by far the most commonly used statistical approach
(e.g. [1, 2]). We suggest here that such approaches are
not optimal when viewing the presence of disease as part
of a complex system. By generalising GLMs into fully
multi-dimensional models - multiple dependent variables
- there exists the potential for considerably greater in-
sight to be gained into complex epidemiological systems.
The Yule-Simpson paradox [3] - that an apparent rela-
tionship between variables may disappear or even be re-
versed when others are taken into account - provides con-
ceptual justiﬁcation. An empirical justiﬁcation is simply
that results from an ABN analysis will generally differ
from an analogous GLM analysis, where the former is
simply a generalisation of the latter. A key distinction be-
tween much of the existing Bayesian network (BN) liter-
ature and ABN modeling, is that the former has focused
largely on conjugate DAG models, thus retaining both
mathematical elegance and computational efﬁciency. In
the important case of binary/multinomial data this leads
to a somewhat unhelpful contingency table parameteri-
sation. In epidemiological analyses ready interpretation9th International Conference on Mathematical Problems in Engineering, Aerospace and SciencesAIP Conf. Proc. 1493, 610-617 (2012); doi: 10.1063/1.4765550©   2012 American Institute of Physics 978-0-7354-1105-0/$30.00610
of the model and its parameters - e.g. odds ratios - are
of paramount importance. This is arguably one reason
why BN modeling is still rare in epidemiology despite
its obvious potential for analysing observational data in
medical and biological studies.
In the following sections we ﬁrst provide a brief
overview of modeling observational data using GLMs,
BNs and ABNs, and how these relate to each other. This
is followed by a veterinary case study which demon-
strates how ABN modeling can be applied to data, and
is contrasted with the use of standard multivariable re-
gression approaches. We conclude with a discussion of
the current limitations and challenges of ABN modeling
and possible future directions.
MODELS FOR OBSERVATIONAL
STUDIES
Observational data is a rather general term and is used
here to denote any form of study where the allocation
of subjects into different treatment groups is beyond the
control of the investigator. Indeed, there may not even
a pre-deﬁned treatment or control group. A popular ex-
ample, particularly in developing countries, are house-
hold surveys. The key point here is that the particular
pattern of covariates which are observed - e.g. responses
to questions in a questionnaire - are determined by un-
known stochastic processes and not the investigator. By
analysing observations from this system it is hoped to
be able to elucidate some of the gross features of these
underlying processes - thereby identify covariates which
may be able to inﬂuence the health of the population.
Multivariable regression into which a variable selec-
tion process is then employed - typically a stepwise
search - is the standard approach used in epidemiological
studies concerned with identifying disease risk factors.
The use of automated variable selection/model compar-
ison techniques - algorithmic approaches in the termi-
nology of Breiman [4] - have historically been viewed
negatively in both the statistical and epidemiological lit-
erature. In contrast, and perhaps not entirely surprisingly,
such automation is strongly embraced by the computer
science and machine learning communities. Bayesian
Networks and ABNs are very much in the spirit of
Breiman’s call for the preferred use of algorithmic tech-
niques in data analysis.
Bayesian Networks
Bayesian network modeling is long established in
the machine learning literature [5, 6]. Relatively re-
cent methodological developments in the area of struc-
ture discovery - identifying optimal models (DAGs) for
given data - include Markov chain Monte Carlo order-
based searching [7] and exact dynamic programming ap-
proaches [8]. The application of BN models in biomedi-
cal science has been rather slow but is increasingly ﬁnd-
ing application in areas such as systems biology [9, 10],
in HIV and inﬂuenza research [11–14], and also analyzes
of complex disease systems [15–17].
Bayesian Networks Model deﬁnition
Figure 1) shows a DAG model for a four dimensional
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FIGURE 1. DAG model for four random variables,
Y1, . . . ,Y4. A Bayesian network comprises of a DAG struc-
ture and a parameterisation. Let Y1, . . . ,Y4 denote binary vari-
ables and πi for i = 1, . . . ,4 denote the probability of observ-
ing a success: P(Yi = 1) = 1−P(Yi = 0). Y1 is independent:
log{π1/(1−π1)}= β1,0;Y2 andY3 are conditionally dependent
upon Y1: log{π2/(1− π2)} = β2,0 + β2,1Y1 and log{π3/(1−
π3)} = β3,0 + β3,1Y1. Y4 is jointly dependent upon Y2 and Y3:
log{π4/(1−π4)}= β4,0 +β4,1Y2 +β4,2Y3. This parameterisa-
tion gives an additive Bayesian network model.
joint probability distribution, f (Y1,Y2,Y3,Y4), where the
arcs denote conditional dependencies. In this example we
have a factorization of f (Y1,Y2,Y3,Y4) = f1(Y1) f2(Y2|Y1)
f3(Y3|Y1) f4(Y4|Y2,Y3). Bayesian networks are decom-
posable [6] - each node can be considered separately -
and we parametrize each node into a local logistic re-
gression model where the goodness of ﬁt and posterior
parameters can be estimated independently within each
node. The observed data for a logistic network model are
tuples of the form {Y1 = d1, . . . ,Ym = dm}, with m = 4
in the example, where m is the total number of random
variables (nodes) in the network model and d j ∈ {0,1}
for j = 1, . . . ,m where P(Yj = 1) = p j = 1−P(Yj = 0).
For ease of notation we use Yj to denote the response
variable at node j and those covariates on which Yj is
conditionally dependent (the nodes parents) as Xk, where
these variables all belong to the same set {Y1, . . . ,Ym}.
A logistic link function is used in each node where
p j,i = exp(xT{ j,i}β j)/{1+exp(xT{ j,i}β j)}where xTj,i is the
ith row in the design matrix X j for node j, and xTj,i =
[x j,i,0, . . . ,x j,i,mj−1] where x j,i,k denotes the value of the
ith observation for the kth covariate in the logistic model611
for node j and x j,i,0 = 1 ∀i, j as a (separate) intercept
term is included at each node. Again for simplicity of
notation local indexing of the covariates at an individual
node is used and is different from the global indexing of
variables j= 1, . . . ,m. We use k for local indexing where
k will always run from k = 0, . . . ,mj − 1. The vector β j
denotes the coefﬁcients for the model at node j and is of
dimension mj.
The likelihood function for node j is
Lj =
N
∏
i=1
(
exp(xT{ j,i}β j)
{1+ exp(xT{ j,i}β j)}
)y j,i
×
(
1
{1+ exp(xT{ j,i}β j)}
)1−y j,i
where N is the total number of observations and complete
data is assumed across all nodes (so N is constant ∀ j).
The total log-likelihood for the data is l = ∑mj=1 logLj.
Priors
We develop our logistic network model within a
Bayesian framework, and priors are therefore required
for the parameters β j for j = 1, . . . ,m, where these are
the usual additive coefﬁcients in a binomial GLM at each
node. A number of different joint priors have been con-
sidered in conjugate categorical BN models, two com-
monly used metrics/priors are the Bayesian Dirichlet
equivalence (BDe) metric and the K2 metric. It has been
shown that the BDe is likelihood equivalent [6] which
is theoretically desirable, in contrast, the K2 metric is
not likelihood equivalent but does assume ﬂat priors for
all parameters, unlike with the BDe metric. Both metrics
have been widely used in practice. To date we are un-
aware of any theoretical work in respect of developing
likelihood equivalent parameter priors for non-conjugate
BNs. In the absence of obvious alternatives and for sim-
plicity we assume independent Gaussian priors for all pa-
rameters. In the subsequent case study analyses uninfor-
mative Gaussian priors with means of zero and variances
of 1000 are used.
As we are searching across DAGs - to identify opti-
mally ﬁtting structures - there is also the need for a prior
on structures. The default being that each structure is
equally supported a priori. It is possible to construct in-
formative structural priors, for example to penalize mod-
els with more structural complexity, e.g. more arcs, but
as noted in [6] these are problematic to specify in prac-
tice. In [8] an informative structural prior on the number
of parents within an individual node is used, where this
assumes that parent combinations with the same cardi-
nality are equally likely. This prior gives equal weighting
to a parent combination with cardinality zero and cardi-
nality m− 1 which may not be entirely desirable. In the
subsequent case study analyses an uninformative - ﬂat -
structural prior is used.
Goodness of ﬁt measures
Structure discovery is all about model selection, and
we consider the usual Bayesian goodness of ﬁt metric,
the marginal likelihood [18] - equivalent to Bayes factors
for models with equal structural priors. In our additive
logistic BN the marginal likelihood (conditional on a
given DAG) for node j is
f j(D j) =
∫ ∞
−∞
[
N
∏
i=1
(
exp(xT{ j,i}β j)
{1+ exp(xT{ j,i}β j)}
)y j,i
×
(
1
{1+ exp(xT{ j,i}β j)}
)1−y j,i⎤⎦
×
mj−1
∏
k=0
1√
2πσk
exp{−(βk −μk)2/(2σ2k )}dβ j
where D j denotes the observed data at node j and com-
prises of tuples of [y j,xTj,i] and recall that vector dβ j is of
dimension mj. The log marginal likelihood for the com-
plete model is therefore f (D) = ∑mj=1 log f j(D j).
The marginal posterior density for an individual pa-
rameter β j,k in node j can be estimated by successively
evaluating equation f j(D j) for a ﬁxed β j,k = b across the
domain −∞ < b < ∞ and dividing by the normalizing
constant f j(D j).
VETERINARY CASE STUDY
We now demonstrate the application of ABN structure
discovery to data from a complex disease system. We
break the structure discovery process into three sequen-
tial steps: i) determine an optimal DAG structure; ii)
assess over-ﬁtting of the structure in i) and if neces-
sary prune excess complexity; iii) adjust the model in
ii) for within group correlation structure (if applicable).
We then have our “optimal” ABN model of the disease
system. Ideally, step iii) would be combined into i) and
we return to this complication later. In the following sec-
tions we illustrate how steps i) through iii) may be imple-
mented. First we introduce the case study data then pro-
vide a simple comparison between using a GLM - equiv-
alent to multivariable logistic regression - to explore this
data and the more general ABN - equivalent to multivari-
ate logistic regression.612
Data
We utilize data on disease occurrence in pigs provided
by the industry body the “British Pig Health Scheme”
(BPHS). The main objective of BPHS is to improve the
productivity of pig production in the UK, and reducing
disease occurrence is a signiﬁcant part of this process.
The data we consider here comprise of a randomly cho-
sen batch of 50 pigs from each of 500 randomly chosen
pig producers in the UK. These are “ﬁnishing pigs”, an-
imals about to enter the human food chain at an abat-
toir. Each animal is assessed for the presence of a range
of different disease conditions by a specialist swine vet-
erinarian. We consider here the following nine disease
conditions: enzootic-pneumonia (EPcat); pleurisy (plbi-
nary); milk spots (MS); hepatic scarring (HS); pericardi-
tis (PC); peritonitis (PT); lung abscess (Abscess); tail
damage (TAIL); and papular dermatitis (PDcat). The
presence of any of these conditions results in an eco-
nomic loss to the producer. Either directly due to the
relevant infected part of the animal being removed from
the food chain, or indirectly in cases such as enzootic-
pneumonia, which may potentially indicate poor herd
health and efﬁciency losses on the farm. An additional
loss, though not directly monetary, is the presence of tail
damage which may be suggestive of welfare concerns,
which may also be linked to sub-optimal production efﬁ-
ciency. Milk spots and hepatic scarring result from infes-
tation with Ascaris suum which is particularly important
as this is a zoonotic helminth parasite [19].
GLM or ABN
Figure 2 shows a globally optimal ABN for the case
study data using the exact order-based search algo-
rithm of [8] implemented in R [20] through the author’s
abn library (which is available for download from the
CRAN website). Note here that there is no arc connect-
ing PC and Abscess. The goodness of ﬁt - log marginal
likelihood - for this model is -44245.73. Forcing into
this model an arc connecting PC and Abscess gives a
far poorer log marginal likelihood of -44249.58 or -
44249.51 (depending on the arc direction). Clearly this
arc is not supported in this globally optimal DAG of the
data.
Now consider a GLM analyses of the same data, where
we consider PC and then Abscess as the response vari-
ables. The parameter and structural priors are identical to
the ABN and a similar exact order-based search is con-
ducted to determine a globally optimal structure. Figure
3 shows the two corresponding DAGs - a GLM is sim-
ply a DAG where arcs are only allowed directly between
the covariates and response variable. In each case we ﬁnd
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FIGURE 2. ABN model - optimal DAG - multivariate logis-
tic regression of disease data
that an arc is identiﬁed between PC and Abscess. More-
over, the marginal posterior density in the GLM (panel a
in Figure 3) for the arc from Abscess to PC strongly sug-
gests that the log odds ratio here is highly signiﬁcantly
different from 0 (Figure 4 with 0 outside the 99.9 per-
centile). Using the reverse arc (panel b in Figure 3) gives
virtually identical results.
In summary, we ﬁnd that the GLM analyses identiﬁes
a strongly supported statistical association between pres-
ence of PC and the presence of Abscess. Applying an
ABN model - a multivariate analogue of the GLM - to the
same data we ﬁnd again that an association between PC
and Abscess is also supported but with a very important
distinction. The ABN model does not support a direct613
PC
Abscess
PT
PC
Abscess plbinary
plbinary
(b)
(a)
FIGURE 3. Two globally optimal GLMs - one with PC as
the dependent variable (a), and a second with Abscess as the
dependent variable (b).
log odds
D
en
si
ty
−5 −4 −3 −2 −1 0
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
FIGURE 4. Marginal Posterior density for covariate Abscess
and response variable PC
statistical dependency between PC and Abscess - there
is no arc connecting these variables. Rather, the relation-
ship (association) between PC and Abscess is via the in-
termediate variable plbinary. This highlights the key dif-
ference between a multivariable GLM and a multivari-
ate GLM (ABN). The former identiﬁes variables which
may be associated with the response (dependent) vari-
able within a very restrictive model space - arcs are only
allowed from covariates direct to the response variable.
When considering the same data within a larger model
space, which incorporates other relationships within the
underlying epidemiological system which generated the
observed data, then such variables may then only be sup-
ported as indirectly - rather than directly - related to the
response variable.
There is a profound difference in epidemiological in-
terpretation between variables that are merely associated
- indirectly dependent - from those which are directly de-
pendent. The latter are natural targets for intervention
strategies, the former - and whilst exceptions do exist
- are typically of much lesser interest. This difference
could be described as addressing lung cancer through
targeting alcohol consumption, on the assumption that
higher alcohol consumption is dependent with smok-
ing, and smoking dependent with lung cancer. Alco-
hol consumption, therefore, is indirectly dependent with
the presence of lung cancer. Obviously, such a strategy
makes little sense compared to targeting smoking itself -
as this would require a reduction in alcohol consumption
to affect a reduction in smoking which then decreases the
risk of lung cancer.
Ultimately, what is desired in epidemiological analy-
ses is to identify variables which are on the casual path-
way of the disease of interest. Whilst this is not possi-
ble using statistical analyses alone - as external informa-
tion, such as a biological mechanism is required - intu-
itively, variables which are only indirectly dependent are
less likely to be on such a pathway. Separating indirectly
from directly dependent variables is, therefore, of con-
siderable practical importance, and a strong justiﬁcation
for preferring an ABN over standard GLM type analyses.
In conclusion, the above example supports that an
ABN approach is not only conceptually preferable for
analysing data which arise from a complex disease sys-
tem, but also that the resulting epidemiological interpre-
tation of its results may also be substantively different
from standard GLM approaches. As an ABN is simply a
more ﬂexible generalisation of a GLM then it is arguable
that an ABN should always be used in preference, as-
suming it is computationally feasible to do so.
Structure Discovery
A particular challenge of ABN structure discovery is
that it is NP-hard to ﬁnd a globally optimal DAG [21].
This has led to the use of methods for iterating over or-
ders rather than DAGs, however, problem size (number
of variables) is still the main practical constraint in ABN
analyses. In epidemiological applications the priority is
typically to identify a single robust structure (e.g. [17]) as
opposed to, for example, the use of model averaging ap-
proaches as clear and transparent interpretation of mod-
eling results is essential.
i) Determine an optimal DAG. The globally optimal
DAG for the case study data of 25000 pigs (Figure 2)
was identiﬁed using an implementation of the order-
based exact search algorithm of [8]. First, an exact search
was conducted using a parent limit constraint of 1 - a614
maximum of one arc to each node. A new exact search
was run this time increasing the parent limit to 2, and
the goodness of ﬁt of these two models compared. If
increasing the parent limit increased the goodness of
ﬁt, then the process was repeated until increasing the
parent limit did not result in a model with improved
ﬁt. This iterative approach is usual to avoid the greatly
increased computation time needed to search across the
model space of DAGs with larger parent limits. The more
direct approach of using a parent limit of m− 1 could
be used immediately but unless m is small then this
search may be both extremely time consuming, indeed
even practically infeasible, and is very inefﬁcient unless a
large enough amount of data is available to support such
densely connected structures. For the case study data a
parent limit of three was sufﬁcient.
ii) Assess over-ﬁtting. A parametric bootstrapping ap-
proach was suggested in [22] which uses simulation to
assess whether a chosen model comprises more com-
plexity than could reasonably be justiﬁed given the size
of the observed data set. Using Markov chain Monte
Carlo simulation via JAGS (open source software), 6000
independent (assumed by inspecting autocorrelations
from the MCMC output) data sets of the same size as
the original data were generated from our chosen model
in i). For each of these bootstrap data sets an identical
exact order-based search as in i) was conducted. Collat-
ing results across these 6000 searches we ﬁnd that only
14% of the globally optimal DAGs found comprised 12
or more arcs. Approximately 68% of DAGs had 11 or
more arcs - therefore a robust model of the original data
has no more than 11 arcs. Almost identical results were
obtained using a random selection of 3000 searches sug-
gesting that sufﬁcient bootstrap samples had been per-
formed. The usual cut-off for structural support of fea-
tures (arcs) is 50% in BN modeling (see [11–14, 16]),
and is analogous to the widespread use of majority con-
sensus trees in phylogenetics. We therefore conclude that
our chosen model in i) with 11 arcs is robust. This is per-
haps not surprising given we have a large data set of 25K
observations.
iii) Adjustment for clustering/correlated observations.
As in many veterinary studies we have a potential corre-
lation structure within our 25K observations, as these are
grouped observations from 500 different pig producers.
This means that over-dispersion may be present in the
data, as while two producers may have identical covari-
ate patterns there are other aspects unique to their farms
which may increase the level of variation beyond what is
possible under binomial sampling. The usual way to re-
solve this is to move from a GLM to a GLMM, a gener-
alised linear mixed model - a GLM which has random ef-
fects now included - which allows for an increase in vari-
ance and within group correlations [23]. The practical
impact of such clustering being that some of the arcs pre-
viously identiﬁed in steps i) and ii) may no longer be sup-
ported after any additional variance due to within group
correlations is included. We use MCMC to ﬁt the model
from ii) to the observed data where now an independent
random effect is included at each node in the model,
where these are all assumed to be Gaussian distributed
with means of zero and diffuse Gamma distributed pre-
cision parameters (shape=0.001 and scale=0.001).
To determine whether any arcs should be dropped,
marginal posterior 95% conﬁdence intervals of the log
odds ratio for each parameter were estimated. If this in-
terval included zero then it was deemed that the corre-
sponding arc did not have sufﬁcient statistical support to
be retained in the model. This resulted in four arcs being
removed from the optimal model identiﬁed in step ii) and
gives us a ﬁnal ABN model (Figure 5).
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FIGURE 5. Final ABN model of disease data after boot-
strapping and clustering adjustment
Our ﬁnal “optimal” model of this disease system sug-
gests that the presence of tail biting is independent from
the other conditions. We also ﬁnd that the remaining
diseases are split into two separate connected compo-
nents. This raises the interesting biological question as to
whether these two groups of diseases may lie on differ-
ent causal pathways, i.e. might the diseases within each
of these groups share common causes. Such results from
data analyses using ABN modeling can be used as a ba-
sis for developing new biological questions about factors
potentially affecting the presence of disease, and inform
the design of future targeted studies.615
DISCUSSION
Two challenges of ABN structure discovery are com-
putational robustness and computationally feasibility.
Structure discovery requires automated and reliable nu-
merical approximation applied to vast numbers of dif-
ferent models. Currently, a Laplace approximation [24]
is used to compute the marginal likelihood for each and
every DAG. To date, we have not included random ef-
fects in this estimation process, but rather have resorted
to the somewhat easier, but less satisfactory situation, of
requiring a third step in our model search process. This
instead uses MCMC simulation, which while easy to im-
plement, can take a very long time indeed to produce re-
liable output when dealing with numerous variables and
numerous random effects. It also does not readily offer
accurate computation of marginal likelihood (although
see [25] for one option). A far better approach would
be to include ABNs with random effects into step i) in
the original model search process. This work is ongoing
and it is as yet an open question as to how challenging
the inclusion of multiple random effects will be in pro-
ducing a robust automated algorithm for computing the
marginal likelihoods across many different models com-
prising of numerous random effect terms. An easier al-
ternative might be to use compound distributions such as
the beta-binomial rather than explicit inclusion of ran-
dom effects.
In terms of computational feasibility, the current im-
plementation of Koivisto’s [8] dynamic programming al-
gorithm is readily feasible up to 20 or so nodes (vari-
ables). Beyond this it becomes rapidly challenging even
on multi-core (cluster computer) hardware. The abn li-
brary in R includes some simple multi-threaded algo-
rithms (using openMP) which provides a considerable
speed-up in computation, but beyond 25 nodes this again
becomes infeasible. It has been demonstrated that it is
computationally possible to perform structural searches
on up to approximately 40 nodes with specialist cluster
speciﬁc algorithms. However, this is not a practical solu-
tion for real world epidemiological applications; if per-
forming an exact search once takes a vast amount of com-
puting then nesting this inside parametric bootstrapping
is clearly not going to be feasible. This is an important
constraint as, generally speaking, BNs tend to consider-
ably over-ﬁt data unless dealing with very large sample
sizes.
In conclusion, data analyses using additive Bayesian
networks have the potential to offer new insights into
complex epidemiological systems. While there are many
exciting computational challenges yet to be addressed
this approach is still feasible for many veterinary and
human medical studies.
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